RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $6,000 | -92.4% | 4,075 | -92.6% | 0.00% | – |
Q4 2023 | $79,000 | +163.3% | 54,925 | +103.4% | 0.00% | – |
Q3 2023 | $30,000 | +50.0% | 26,998 | +66.9% | 0.00% | – |
Q2 2023 | $20,000 | -81.0% | 16,179 | -79.6% | 0.00% | – |
Q1 2023 | $105,000 | -71.4% | 79,167 | -67.6% | 0.00% | – |
Q4 2022 | $367,000 | +230.6% | 244,037 | +160.5% | 0.00% | – |
Q3 2022 | $111,000 | +1750.0% | 93,665 | +1763.6% | 0.00% | – |
Q2 2022 | $6,000 | -87.0% | 5,026 | -67.6% | 0.00% | – |
Q1 2022 | $46,000 | -59.3% | 15,498 | -63.5% | 0.00% | – |
Q4 2021 | $113,000 | +37.8% | 42,424 | +88.3% | 0.00% | – |
Q3 2021 | $82,000 | +15.5% | 22,533 | +39.1% | 0.00% | – |
Q2 2021 | $71,000 | +18.3% | 16,198 | -8.8% | 0.00% | – |
Q1 2021 | $60,000 | +2900.0% | 17,761 | +1809.8% | 0.00% | – |
Q3 2020 | $2,000 | -91.7% | 930 | -92.8% | 0.00% | – |
Q2 2020 | $24,000 | -46.7% | 12,933 | -55.9% | 0.00% | – |
Q1 2020 | $45,000 | +1400.0% | 29,347 | +1850.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 1,505 | +0.3% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 1,500 | -1.4% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 1,522 | +0.1% | 0.00% | – |
Q1 2019 | $4,000 | -20.0% | 1,521 | -39.2% | 0.00% | – |
Q4 2018 | $5,000 | -66.7% | 2,500 | -47.0% | 0.00% | – |
Q3 2018 | $15,000 | +114.3% | 4,714 | +88.6% | 0.00% | – |
Q2 2018 | $7,000 | -22.2% | 2,500 | 0.0% | 0.00% | – |
Q1 2018 | $9,000 | -10.0% | 2,500 | -3.1% | 0.00% | – |
Q4 2017 | $10,000 | -63.0% | 2,580 | -76.2% | 0.00% | – |
Q3 2017 | $27,000 | +2600.0% | 10,824 | +3092.9% | 0.00% | – |
Q2 2017 | $1,000 | -93.8% | 339 | -93.0% | 0.00% | – |
Q1 2017 | $16,000 | +33.3% | 4,851 | -2.2% | 0.00% | – |
Q4 2016 | $12,000 | +500.0% | 4,961 | +892.2% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 500 | -30.7% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 722 | -12.2% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 822 | -13.4% | 0.00% | – |
Q4 2015 | $3,000 | -75.0% | 949 | -80.6% | 0.00% | – |
Q3 2015 | $12,000 | -36.8% | 4,899 | -15.7% | 0.00% | – |
Q2 2015 | $19,000 | +1800.0% | 5,809 | +1924.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 287 | +29.3% | 0.00% | – |
Q4 2014 | $1,000 | – | 222 | 0.0% | 0.00% | – |
Q3 2014 | $0 | -100.0% | 222 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | -96.6% | 222 | -97.2% | 0.00% | – |
Q3 2013 | $29,000 | -38.3% | 8,021 | -43.0% | 0.00% | – |
Q2 2013 | $47,000 | – | 14,075 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |